Allarity Therapeutics Accelerates Trial Enrollment To Bring FDA-Approved ...
Allarity Therapeutics Accelerates Trial Enrollment To Bring FDA-Approved ...
Stay updated with breaking news from Thomas Pedersen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Allarity Therapeutics Accelerates Trial Enrollment To Bring FDA-Approved ...
This Combination Therapy Could Help Change Cancer Treatment - Take ...
CAMBRIDGE, MA / ACCESSWIRE / April 17, 2023 / Allarity Therapeutics (NASDAQ:ALLR) dosed its first patient in Phase 1b of its clinical trial for the novel combination therapy of two drugs, stenoparib and
Efforts underway to accelerate patient recruitment and amend protocols to improve patient outcomes. Interim data readouts for both studies anticipated in H2 2023. Press release BOSTON —... | March 28, 2023
Common Stock Will Begin Trading on a Post-Split Adjusted Basis on March 27, 2023 Press releaseBOSTON, Mass - March 24, 2023 - Allarity Therapeutics, Inc. (Nasdaq: ALLR) ("Allarity" or the "Company"), a